Showing 1 to 10 of 16 clinical trials
1 | 2 |
CLINICAL TRIALS
    Trial No
    ClinicalTrials.gov ID
Phase Coordinator
A Multicenter, Double-blind, Randomized Phase 3 Study to Compare the Efficacy and Safety of Belzutifan Plus Pembrolizumab Versus Placebo Plus Pembrolizumab, in the Adjuvant Treatment of Clear Cell Renal Cell Carcinoma (ccRCC) Post Nephrectomy
    MK-6482-022
    NCT05239728
     Recruiting
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
Rodrigo Skowronski
514-934-1934 poste 36275
Surveillance of Complex Renal Cysts - The SOCRATIC Study
    SOCRATIC
    NCT04558593
     Recruiting
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
Rodrigo Skowronski
514-934-1934 poste 36275
A Single Arm, Multicenter, Phase 2 Trial to Evaluate the Efficacy of Lenvatinib (LEN) in Combination With Pembrolizumab (KEYtruda) in Subjects With Locally Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma
    The LENKYN Trial
    NCT04267120
     Recruiting
CHU DE QUEBEC – UNIVERSITE LAVAL
L'HOTEL-DIEU DE QUEBEC ET CRCEO
Marilyn Savard
418-525-4444 poste 20414
A Multicenter, Double-blind, Randomized Phase 3 Study to Compare the Efficacy and Safety of Belzutifan Plus Pembrolizumab Versus Placebo Plus Pembrolizumab, in the Adjuvant Treatment of Clear Cell Renal Cell Carcinoma (ccRCC) Post Nephrectomy
    MK-6482-022
    NCT05239728
     Recruiting
CHU DE QUEBEC – UNIVERSITE LAVAL
HOPITAL DE L'ENFANT-JESUS
Marilyn Savard
418-525-4444 poste 20414
An Open-label, Randomized Phase 3 Study to Evaluate Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or MK-1308A in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, as First-Line Treatment in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
    MK-6482-012
    NCT04736706
     Recruiting
CHU DE QUEBEC – UNIVERSITE LAVAL
L'HOTEL-DIEU DE QUEBEC ET CRCEO
Marilyn Savard
418-525-4444 poste 20414
Proposition canadienne d’une base de données d’un système d'information du Cancer du rein
    BANQUE DE DONNÉES CKCis
     Recruiting
CHU DE QUEBEC – UNIVERSITE LAVAL
L'HOTEL-DIEU DE QUEBEC ET CRCEO
Marilyn Savard
418-525-4444 poste 20414
Surveillance of Complex Renal Cysts - The SOCRATIC Study
    SOCRATIC
    NCT04558593
     Recruiting
CHU DE QUEBEC – UNIVERSITE LAVAL
HOPITAL DE L'ENFANT-JESUS
Marilyn Savard
418-525-4444 poste 20414
Surveillance of Complex Renal Cysts - The SOCRATIC Study
    SOCRATIC
    NCT04558593
     Recruiting
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
Amal Nadiri
514-890-8000 poste 26074
Proposition canadienne d’une base de données d’un système d'information du Cancer du rein
    Registre cancer du rein CKCis
     Recruiting
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
Louise Rousseau
514-890-8000 poste 35732
Surveillance of Complex Renal Cysts - The SOCRATIC Study
    SOCRATIC
    NCT04558593
     Recruiting
CIUSSS DE L'EST-DE-L'ILE-DE-MONTREAL
PAV. MAISONNEUVE/PAV. MARCEL-LAMOUREUX
Audrey Lamoureux
514-252-3400 poste 6258

Samara Bloom
514-252-3400 poste 6244
1 | 2 |